Alyssa R. Henriquez BS, Bryan Crook MD, Lindsey V. Ruderman BA, Aaron Therien BS, Eoghan T. Hurley MB, MCh, PhD, Christopher Klifto MD, Oke Anakwenze MD MBA, Michael A. Moverman MD
{"title":"Operative treatment is associated with improved 3-year survival after periprosthetic humerus fracture","authors":"Alyssa R. Henriquez BS, Bryan Crook MD, Lindsey V. Ruderman BA, Aaron Therien BS, Eoghan T. Hurley MB, MCh, PhD, Christopher Klifto MD, Oke Anakwenze MD MBA, Michael A. Moverman MD","doi":"10.1016/j.jseint.2026.101688","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>This study examines the survival implications of operative versus nonoperative management of periprosthetic humerus fractures in a large, single-center cohort.</div></div><div><h3>Methods</h3><div>Patients at a single tertiary care center with periprosthetic humerus fractures about a shoulder prosthesis between January 2013 and March 2024 were retrospectively identified. Patients were stratified according to operative versus nonoperative treatment. The primary outcome was all-cause mortality. Survival was compared using Kaplan–Meier curves and log-rank tests. Prespecified time horizons were 90 days, 1 year, 2 years, and 3 years.</div></div><div><h3>Results</h3><div>Ninety patients with periprosthetic fractures were identified (23 nonoperative, 67 operative). There were 13 total deaths (8/23 [35%] nonoperative, 5/67 [7.5%] operative). Baseline characteristics were largely similar aside from a higher body mass index in the operative group (32 vs. 29 kg/m<sup>2</sup>, <em>P</em> = .046). Age (nonoperative: 74 vs. operative: 71 years, <em>P</em> = .30), sex (<em>P</em> = .40), hand dominance (<em>P ></em> .9), race (<em>P =</em> .07), smoking (<em>P =</em> .40), comorbidity burden (Elixhauser weighted and count <em>P</em> = .20 and <em>P</em> = .60, respectively), and Charlson distribution (<em>P</em> = .20) were all similar between groups. On Kaplan–Meier analysis, early mortality was rare: 90-day survival was 95.7% in the nonoperative group versus 100.0% in the operative group (<em>P</em> = .09). Survival differences widened over time, becoming significant at 3 years after the injury: 1 year (nonoperative: 95.7%; operative: 98.5%; <em>P</em> = .42), 2 years (nonoperative: 90%, operative: 98.5%; <em>P</em> = .09), and 3 years (nonoperative: 72.2%; operative: 96.5%; <em>P</em> = .004).</div></div><div><h3>Conclusions</h3><div>Surgical fixation of periprosthetic humerus fractures is associated with lower mortality that becomes apparent in a delayed fashion and grows over time. By 3 years after the injury, the mortality difference approached 25% between operatively and nonoperatively treated patients. These findings should be validated in larger, multicenter studies.</div></div>","PeriodicalId":34444,"journal":{"name":"JSES International","volume":"10 3","pages":"Article 101688"},"PeriodicalIF":2.0000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JSES International","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666638326000733","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background
This study examines the survival implications of operative versus nonoperative management of periprosthetic humerus fractures in a large, single-center cohort.
Methods
Patients at a single tertiary care center with periprosthetic humerus fractures about a shoulder prosthesis between January 2013 and March 2024 were retrospectively identified. Patients were stratified according to operative versus nonoperative treatment. The primary outcome was all-cause mortality. Survival was compared using Kaplan–Meier curves and log-rank tests. Prespecified time horizons were 90 days, 1 year, 2 years, and 3 years.
Results
Ninety patients with periprosthetic fractures were identified (23 nonoperative, 67 operative). There were 13 total deaths (8/23 [35%] nonoperative, 5/67 [7.5%] operative). Baseline characteristics were largely similar aside from a higher body mass index in the operative group (32 vs. 29 kg/m2, P = .046). Age (nonoperative: 74 vs. operative: 71 years, P = .30), sex (P = .40), hand dominance (P > .9), race (P = .07), smoking (P = .40), comorbidity burden (Elixhauser weighted and count P = .20 and P = .60, respectively), and Charlson distribution (P = .20) were all similar between groups. On Kaplan–Meier analysis, early mortality was rare: 90-day survival was 95.7% in the nonoperative group versus 100.0% in the operative group (P = .09). Survival differences widened over time, becoming significant at 3 years after the injury: 1 year (nonoperative: 95.7%; operative: 98.5%; P = .42), 2 years (nonoperative: 90%, operative: 98.5%; P = .09), and 3 years (nonoperative: 72.2%; operative: 96.5%; P = .004).
Conclusions
Surgical fixation of periprosthetic humerus fractures is associated with lower mortality that becomes apparent in a delayed fashion and grows over time. By 3 years after the injury, the mortality difference approached 25% between operatively and nonoperatively treated patients. These findings should be validated in larger, multicenter studies.